台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    116.0
  • 漲跌
    ▼1.0
  • 漲幅
    -0.85%
  • 成交量
    70
  • 產業
    上櫃 文化創意指數
  • 105人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
智基 (6294)籌碼相關-玉山-松江 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

玉山-松江 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2020/06/1800.001114.00115.00-154-1.84%
2020/06/051113.5000.00113.001551.79%
2020/05/2100.001110.00110.00-152-1.89%
2020/05/1800.0010107.30108.00-1051-19.61%
2020/05/1500.002108.50108.00-250-3.97%
2020/05/1100.002106.00106.00-244-4.48%
2020/04/2900.004101.50101.50-442-9.33%
2020/04/2310100.005100.00100.0054411.16%
2020/04/1700.0014100.18100.50-1443-32.32%
2020/04/14899.701099.64101.00-242-4.71%
2020/04/13198.90299.3099.20-142-2.34%
2020/04/0900.00498.63100.00-442-9.33%
2020/03/27296.30296.3095.000410.00%
2020/03/251496.901496.9095.700400.00%
2020/03/2000.00285.4084.50-238-5.16%
2020/03/131193.3200.0095.10113333.18%
2020/03/10299.9500.00100.002287.08%
2020/03/092499.9900.00100.00242787.11%
2020/02/1200.003101.00101.00-326-11.19%
2019/12/181102.5000.00102.501204.99%
2019/11/051102.004102.00102.00-321-13.91%
2019/10/311101.5000.00101.501214.56%
2019/10/2100.001102.00102.00-123-4.23%
2019/10/1800.009102.00101.50-924-36.99%
2019/09/2600.005102.50102.50-532-15.44%
2019/09/181102.0000.00102.001372.69%
2019/09/0510102.0000.00102.00104124.16%
2019/04/1000.0041108.13108.00-4135-114.26%
2019/04/0900.006109.00109.00-635-16.93%
2019/04/0800.003108.00108.50-335-8.57%
2019/04/0300.001107.50107.50-134-2.87%
2019/04/0200.001107.50107.50-134-2.92%
2019/04/011108.0000.00107.501323.07%
2019/03/281108.5000.00108.501313.16%
2019/03/2700.002110.75109.50-231-6.33%
2019/03/2600.0010110.15111.00-1030-32.28%
2019/03/252109.5000.00109.502306.47%
2019/03/182112.5000.00111.502267.57%
2019/03/1424110.0000.00110.00242594.18%
2019/03/137109.5700.00110.0072527.47%
2019/03/0800.001109.00109.00-125-3.90%
2019/03/0700.001109.00109.00-125-3.91%
2019/03/0400.001109.50110.00-125-3.93%
2019/02/2600.001110.00109.00-124-4.10%
2019/02/2100.001108.50108.00-123-4.30%
2019/02/1900.001108.00108.50-122-4.51%
2019/02/1500.001108.00108.00-121-4.56%
2019/02/130.2106.501107.00107.00-0.821-3.92%
2019/02/111106.5000.00106.501214.56%
2019/01/2800.001105.50106.00-122-4.40%
2019/01/2400.001105.50105.50-123-4.27%
2019/01/220.2105.001105.00105.00-0.824-3.18%
2019/01/1800.001106.00106.00-124-4.02%
2019/01/1500.004107.00106.50-425-15.87%
2019/01/100.5105.001104.50105.00-0.524-2.16%
2019/01/0800.001103.50103.00-124-4.09%
2019/01/032103.001103.50103.001273.63%
2018/12/2700.001103.00102.50-128-3.54%
2018/12/2400.001103.00102.50-127-3.62%
2018/12/2100.001101.50102.00-127-3.61%
2018/12/1900.002103.00102.50-226-7.47%
2018/11/1900.0014103.11103.50-1429-48.11%
2018/11/151104.5000.00104.001293.41%
2018/11/131103.5000.00103.001293.40%
2018/11/081107.0000.00105.501283.48%
2018/11/061107.0000.00106.001293.39%
2018/11/0500.000.1107.00106.00-0.130-0.36%
2018/11/011100.001101.50102.000290.00%
2018/10/30199.1000.0098.701293.45%
2018/10/25199.0000.0099.601303.27%
2018/10/23199.5000.0099.401323.05%
2018/10/18199.8000.00100.501392.51%
2018/10/16199.9000.0099.601432.32%
2018/10/11499.1800.0098.804449.01%
2018/10/092102.0000.00101.502434.61%
2018/10/081103.0000.00102.001452.22%
2018/10/041105.5000.00105.001452.21%
2018/10/031106.5000.00105.001452.19%
2018/08/210.1112.0000.00111.000.1580.17%
2018/08/172109.7500.00109.502603.29%
2018/07/2000.001125.50126.50-184-1.19%
2018/06/2700.000.1124.00124.50-0.193-0.05%
2018/06/111126.0000.00126.5011210.82%
2018/06/0700.001127.00126.50-1122-0.82%
2018/05/171125.0000.00125.0011280.78%
2018/05/1100.000.1125.00124.50-0.1130-0.08%
2018/05/0800.001132.00130.50-1126-0.79%
2018/04/1700.001123.50122.00-1163-0.61%
2018/03/3000.001130.50129.50-1161-0.62%
2018/03/220.1125.5000.00125.500.11700.06%
2018/03/2000.001127.50127.50-1178-0.56%
2018/03/193127.5000.00127.5031761.70%
2018/03/1200.000.1120.00120.00-0.1171-0.06%
2018/01/251126.501124.00123.5001610.00%
2018/01/2300.001123.00123.00-1155-0.64%
2018/01/191127.003126.83124.00-2148-1.35%
2018/01/1700.001121.50121.50-1129-0.77%
2018/01/101112.0000.00112.0011020.98%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音